Medical Devices News and Research

RSS

Glide Pharma announces successful completion of pre-clinical proof-of-concept study with novel solid formulation of octreotide acetate

Glide Pharma, the pharmaceutical development and device company focused on solid dose formulations of therapeutics and vaccines, today announced that its novel solid formulation of octreotide acetate achieved successful results in a pre-clinical proof-of-concept study comparing it with the currently marketed liquid product (Sandostatin®).

22 Jul 2014

New poll finds consumers have trouble comparing physicians' quality of care

Americans consider insurance and a good bedside manner in choosing a doctor, but will that doctor provide high-quality care? A new poll shows that people don't know how to determine that. Being licensed and likable doesn't necessarily mean a doctor is up to date on best practices. But consumers aren't sure how to uncover much more. Just 22 percent of those questioned are confident they can find information to compare the quality of local doctors, according to the poll by The Associated Press-NORC Center for Public Affairs Research (7/20).

22 Jul 2014

Johnson & Johnson sales increase 9.1% to $19.5 billion in second quarter 2014

Johnson & Johnson today announced sales of $19.5 billion for the second quarter of 2014, an increase of 9.1% as compared to the second quarter of 2013. Operational results increased 9.4% and the negative impact of currency was 0.3%.

15 Jul 2014

New rules on 'off-label' drug marketing expected

The FDA is reviewing what kind of data drug companies should be allowed to give doctors about off-label uses with a goal of issuing guidelines by year's end.

14 Jul 2014

Veran announces positive, final results for initial study of SPiNPerc procedure

Veran Medical Technologies, a U.S. based medical device company, announced today the positive, cost-effective final results for the initial study of its innovative SPiNPerc procedure.

11 Jul 2014

First Edition: July 11, 2014

Today's headlines include coverage of surveys that offer insight into how the health law is doing in terms of reducing the nation's rate of uninsurance.

11 Jul 2014

NAFC updates Male Stress Urinary Incontinence content

The National Association For Continence (NAFC) has updated the Male Stress Urinary Incontinence content at www.nafc.org. The new content is designed to be more patient friendly and includes an educational video, as well as additional resources about the diagnosis, treatment, and management of Male Stress Urinary Incontinence.

11 Jul 2014

Wall Street seeks big bang from urgent care

Urgent care has mushroomed into an estimated $14.5 billion business, as investors try to profit from changes in health care, reports The New York Times.

11 Jul 2014

Endomedix develops spray-on gel to staunch bleeding during brain surgery

Endomedix, a start-up company housed at NJIT's business incubator, received a $1.4 million federal grant to develop a spray-on gel that surgeons will use to staunch bleeding during brain surgery.

11 Jul 2014

Cook Medical’s Evolution® RL Lead Extraction Products reintroduced to the US market

Effective immediately, Cook Medical customers in the United States will again have access to its Evolution® RL and Evolution® Shortie RL Controlled-Rotation Dilator Sheath Sets. Distribution of these products within the U.S. market was suspended for two months while Cook’s Lead Management clinical division worked with the U.S. Food and Drug Administration (FDA) to resolve agency questions about the marketing clearance of these products. The devices, which remained available in Europe and other markets, were not recalled by FDA.

From COOK MEDICAL INC. 10 Jul 2014

NIH funds Phase II 90-subject pediatric clinical trial at UCLA

NeuroSigma, Inc., a California-based life sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that the U.S. National Institutes of Health (NIH) has awarded UCLA a grant that funds a Phase II 90-subject pediatric clinical trial at the University of California, Los Angeles focused on the treatment of Attention Deficit Hyperactivity Disorder (ADHD) with NeuroSigma's external trigeminal nerve stimulation (eTNS) System.

10 Jul 2014

UCLA project receives $15M to restore lost memory functions in brain-injured people

The UCLA Program in Memory Restoration has been awarded up to $15 million by the Defense Advanced Research Projects Agency (DARPA) for a four -year project aiming to help brain-injured people restore lost memory functions.

9 Jul 2014

Medicare mulls expanding telehealth to wellness, behavioral visits

The proposed rule would also pay for rural telemedicine for providers who are closer to big cities. Elsewhere, telemedicine in treating injured workers -- especially in rural areas -- catches on.

8 Jul 2014

RD Biomed announces Chinese distribution agreement for reflux diagnostic tool Peptest

RD Biomed, the Yorkshire medical technology company, has announced a Chinese distribution agreement for its world-leading reflux diagnostic tool Peptest.

8 Jul 2014

Battelle acquires nearly 11% of AMIC's outstanding Common Stock

Advanced Medical Isotope Corporation, a late stage development company engaged primarily in the development of brachytherapy devices and medical isotopes for diagnostic and therapeutic applications, today announced that Battelle, has acquired approximately 11% of AMIC's outstanding Common Stock.

7 Jul 2014

New way to combat bacterial biofilm formation with titanium encrusted with gold nanoparticles

Bacteria love to colonize surfaces inside your body, but they have a hard time getting past your rugged, salty skin.

1 Jul 2014

ARKON receives Medical Design Excellence Awards at 17th Annual MDEA Ceremony

Spacelabs Healthcare's Anesthesia Delivery System, ARKON™, received the Medical Design Excellence Awards Silver Winner in Critical-Care and Emergency Medicine Products at the 17th Annual MDEA Ceremony earlier this month.

1 Jul 2014

Rotation Medical secures $27.2 million in oversubscribed Series B financing

Rotation Medical, a medical device company focused on developing new technologies to treat rotator cuff disease, today announced that it has secured $27.2 million in an oversubscribed Series B financing.

1 Jul 2014

Telerx acquires C3i to expand business services outside the United States

Telerx, a leader in U.S. customer care services, today announced that it has completed its acquisition of C3i, a leading provider of technology support services for the life sciences industry. This acquisition will provide Telerx with the global infrastructure to expand its business services outside the United States while maintaining its current domestic operations. The acquisition was completed on June 30, 2014.

1 Jul 2014

Lombard Medical exhibits Aorfix system at Critical Issues in Aortic Endografting symposium

Lombard Medical, Inc, a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAA), exhibited its Aorfix Endovascular stent graft system at the 18th international experts' symposium, Critical Issues in Aortic Endografting, in Malmö, Sweden on June 27-28, 2014.

30 Jun 2014